Dr. Gustavo Bernardes de Figueiredo Oliveira

Hospital: Instituto Dante Pazzanese de Cardiologia

Av Dr. Dante Pazzanese, 500. CEP04012-909. Ibirapuera, São Paulo, SP, Brasil

Fone: Unidade Coronária: (11) 5085 6300; celular: (11) 8401 9897

Atividades: Cardiologista Assistente,Unidade CoronÁria; Investigador, Sub-investigador, e Coordenação Nacional de Estudos Clínicos em doenças Cardiovasculares, Divisão de Pesquisa/UPEC

FORMAÇÃO ACADÊMICA EAPERFEIÇOAMENTO PROFISSIONAL:

GRADUAÇÃO:Medicina, Universidade Federal de Uberlândia, Minas Gerais, Brasil (1995)

RESIDÊNCIA: Medicina Interna, Universidade Federal de Uberlândia, Minas Gerais, Brasil (1997); Cardiologia, Instituto Dante Pazzanese de Cardiologia, Sâo Paulo, Brasil (1999); Medicina Intensiva em Cardiologia, Instituto Dante Pazzanese de Cardiologia, Sâo Paulo, Brasil (2000)

Pós-Graduação: “Fellowship” em Pesquisa Clínica e Unidade CoronÁria, Duke Clinical Research Institute, Duke University, North Carolina, EUA (2003-2005)

PhD: Cardiologia, Instituto Dante Pazzanese de Cardiologia, Universidade de São Paulo (2007-2011)

ESTUDOS CLÍNICOS REALIZADOS:Participação como sub-investigador nos seguintes estudos: ASSENT 3; GIK II; TETAMI; OASIS 4, 5, 6; EXPEDITION; RAPSODY;

AMISTAD II; ATO Z; VALIANT; SYNERGY; SHINE; TRITON; EXTRACT – TIMI 25; IMPROVE-IT; INTENSIVE; ADOPT; TRILOGY (em andamento); AXIOM-ACS; DAL-OUTCOMES (em andamento); ROCKET-AF); SOLID TIMI-52 (em andamento). Participação em ECR como Investigador Principal: HOPE-3 (em andamento); ARISTOTLE (em andamento); AVERROES; EPICOR (em andamento).

PESQUISA CLÍNICA: pesquisa de qualidade de tratamento e eventos cardiovascuLares em síndromes coronÁrias agudas, risco cardiometabólico, trombocitopenia induzida por heparina

PUBLICAÇÕES RECENTES: Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective.

Spencer FA, Montalescot G, Fox KA, Goodman SG, Granger CB, Goldberg RJ, Oliveira GB, Anderson FA, Eagle KA, Fitzgerald G, Gore JM; Global Registry of Acute Coronary Events (GRACE) Investigators.

Eur Heart J. 2010 Jun;31(11):1328-36. Epub 2010 Mar 15.PMID: 20231154.

Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).

Lopes RD, Ohman EM, Granger CB, Honeycutt EF, Anstrom KJ, Berger PB, Crespo EM, Oliveira GB, Moll S, Moliterno DJ, Abrams CS, Becker RC.

Am J Cardiol. 2009 Nov 1;104(9):1285-91.PMID: 19840578.

Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin.

Jolicoeur EM, Ohman EM, Honeycutt E, Becker RC, Crespo EM, Oliveira GB, Moliterno DJ, Anstrom KJ, Granger CB. Am J Cardiol. 2009 Jul 15;104(2):292-7. Epub 2009 Jun 3.PMID: 19576363.

Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.

Crespo EM, Oliveira GB, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Granger CB, Ohman EM; CATCH Registry Investigators. Am Heart J. 2009 Apr;157(4):651-7. Epub 2009 Mar 17.PMID: 19332191.

Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.

Oliveira GB, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB; Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators. Arch Intern Med. 2008 Jan 14;168(1):94-102.PMID: 18195201.

Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification.

Oliveira GB, Avezum A, Anderson FA Jr, Budaj A, Dabbous OH, Goodman SG, Steg PG, Goldberg RJ, Brieger D, Fox KA, Gore JM, Granger CB; GRACE Investigators.

Am Heart J. 2007 Apr;153(4):493-9.PMID: 17383284.

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.

Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GB, Todaro TG, Mojcik CF, Armstrong PW, Granger CB.

Eur Heart J. 2006 Jun;27(11):1289-97. Epub 2006 Apr 12.PMID: 16611669.

Highlights from the American College of Cardiology Annual Scientific Session 2005: March 6 to 9, 2005, Orlando, Florida.

Patel MR, Baeza RG, Goyal A, Halabi AR, Melloni C, Oliveira GB, Tricoci P, Valente AM.

Am Heart J. 2005 Jun;149(6):1009-19. No abstract available. PMID: 15976782.